Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients
FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product. 		FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
POVIDONE K29-32 ORAL; CAPSULE
POVIDONE K29-32 ORAL; CAPSULE, ENTERIC COATED PELLETS
POVIDONE K29-32 ORAL; CAPSULE, EXTENDED RELEASE
POVIDONE K29-32 ORAL; CAPSULE, SUSTAINED ACTION
POVIDONE K29-32 ORAL; GRANULE
POVIDONE K29-32 ORAL; SOLUTION
POVIDONE K29-32 ORAL; TABLET
POVIDONE K29-32 ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
POVIDONE K29-32 ORAL; TABLET, COATED
POVIDONE K29-32 ORAL; TABLET, CONTROLLED RELEASE
POVIDONE K29-32 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
POVIDONE K29-32 ORAL; TABLET, ENTERIC COATED PARTICLES
POVIDONE K29-32 ORAL; TABLET, EXTENDED RELEASE
POVIDONE K29-32 ORAL; TABLET, FILM COATED
POVIDONE K29-32 ORAL; TABLET, MULTILAYER, COATED
POVIDONE K29-32 ORAL; TABLET, SUSTAINED ACTION
POVIDONE K29-32 ORAL-21; TABLET
POVIDONE K29-32 ORAL-28; TABLET
POVIDONE K29-32 ORAL-28; TABLET, COATED
POVIDONE K29-32 SUBLINGUAL; TABLET
POVIDONE K29-32 TRANSDERMAL; FILM, CONTROLLED RELEASE
POVIDONE K29-32 VAGINAL; TABLET
POVIDONE K30 OPHTHALMIC; SUSPENSION
POVIDONE K30 ORAL; CAPSULE
POVIDONE K30 ORAL; CAPSULE, EXTENDED RELEASE
POVIDONE K30 ORAL; CAPSULE, HARD GELATIN
POVIDONE K30 ORAL; CAPSULE, SOFT GELATIN
POVIDONE K30 ORAL; CAPSULE, SOFT GELATIN LIQUID-FILLED
POVIDONE K30 ORAL; CAPSULE, SUSTAINED ACTION
POVIDONE K30 ORAL; DISPERSIBLE TABLET
POVIDONE K30 ORAL; GRANULE, EFFERVESCENT
POVIDONE K30 ORAL; LIQUID
POVIDONE K30 ORAL; POWDER, FOR SUSPENSION
POVIDONE K30 ORAL; TABLET
POVIDONE K30 ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
POVIDONE K30 ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT
POVIDONE K30 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
POVIDONE K30 ORAL; TABLET, EXTENDED RELEASE
POVIDONE K30 ORAL; TABLET, FILM COATED
POVIDONE K30 ORAL; TABLET, ORALLY DISINTEGRATING
POVIDONE K30 ORAL; TABLET, SUSTAINED ACTION
POVIDONE K30 ORAL-21; TABLET
POVIDONE K30 ORAL-28; TABLET
POVIDONE K30 SUBLINGUAL; TABLET
POVIDONE K90 ORAL; CAPSULE
POVIDONE K90 ORAL; CAPSULE, EXTENDED RELEASE
POVIDONE K90 ORAL; CAPSULE, HARD GELATIN
POVIDONE K90 ORAL; CAPSULE, SUSTAINED ACTION
POVIDONE K90 ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN
POVIDONE K90 ORAL; GRANULE, FOR SUSPENSION
POVIDONE K90 ORAL; TABLET
POVIDONE K90 ORAL; TABLET, COATED
POVIDONE K90 ORAL; TABLET, CONTROLLED RELEASE
POVIDONE K90 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
POVIDONE K90 ORAL; TABLET, ENTERIC COATED PARTICLES
POVIDONE K90 ORAL; TABLET, EXTENDED RELEASE
POVIDONE K90 ORAL; TABLET, FILM COATED
POVIDONE K90 ORAL; TABLET, SUSTAINED ACTION
POVIDONE K90 ORAL-28; TABLET
POVIDONE K90 TOPICAL; SOLUTION
POVIDONE K90F ORAL; TABLET, SUSTAINED ACTION
PPG-12/SMDI COPOLYMER TOPICAL; EMULSION, CREAM
PPG-12/SMDI COPOLYMER TOPICAL; GEL
PPG-15 STEARYL ETHER TOPICAL; OINTMENT
PPG-20 METHYL GLUCOSE ETHER DISTEARATE TOPICAL; GEL
PPG-26 OLEATE TOPICAL; EMULSION, CREAM
PRIMAJEL ORAL; TABLET
PRIMARY TASTE MODIFIER # 29275 ORAL; SYRUP
PRODUCT WAT TOPICAL; AEROSOL
PROLINE IV(INFUSION); INJECTION
PROLINE IV(INFUSION); SOLUTION, INJECTION
PROMALGEN TYPE G TOPICAL; LOTION
PROMULGEN D TOPICAL; LOTION
PROMULGEN D VAGINAL; EMULSION, CREAM
PROMULGEN G TOPICAL; EMULSION, CREAM
PROMULGEN G TOPICAL; LOTION
PROMULGEN G TOPICAL; SHAMPOO
PROPANE TOPICAL; AEROSOL, SPRAY
PROPANE TOPICAL; EMULSION, AEROSOL FOAM
PROPELLANT A-46 TOPICAL; EMULSION, AEROSOL FOAM
PROPENYL GUAETHOL ORAL; CAPSULE
PROPYL GALLATE INTRAMUSCULAR; INJECTION
PROPYL GALLATE ORAL; CAPSULE, SOFT GELATIN
PROPYL GALLATE ORAL; CONCENTRATE
PROPYL GALLATE ORAL; TABLET
PROPYL GALLATE ORAL; TABLET, SUSTAINED ACTION
PROPYL GALLATE ORAL; TABLET, SUSTAINED ACTION, COATED
PROPYL GALLATE TOPICAL; EMULSION, CREAM
PROPYL GALLATE TOPICAL; GEL
PROPYL GALLATE TOPICAL; OINTMENT
PROPYLENE CARBONATE TOPICAL; OINTMENT
PROPYLENE GLYCOL AURICULAR (OTIC); SOLUTION
PROPYLENE GLYCOL AURICULAR (OTIC); SOLUTION, DROPS
PROPYLENE GLYCOL AURICULAR (OTIC); SUSPENSION
PROPYLENE GLYCOL DENTAL; PASTE
PROPYLENE GLYCOL DENTAL; SOLUTION
PROPYLENE GLYCOL EXTRACORPOREAL; SOLUTION
PROPYLENE GLYCOL IM - IV; INJECTION
PROPYLENE GLYCOL IM - IV; SOLUTION, INJECTION
PROPYLENE GLYCOL INHALATION; SOLUTION

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link